Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Lipodystrophies

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Lipodystrophies

Kelly Quinn et al.
Free Books & Documents

Excerpt

Lipodystrophies are the category of conditions that share the common finding of a reduction in subcutaneous fat. There are multiple subtypes of lipodystrophy, which may be either congenital or acquired and vary in the distribution of fat loss. Although all are relatively rare in incidence, acquired variants have become more common as an adverse effect of certain medications and iatrogenic mechanisms. Regardless of subtype, decreases in overall adipose burden may lead to metabolic complications, with subsequent increases in morbidity and mortality in lipodystrophy patients.

Congenital Generalized Lipodystrophy

Congenital generalized lipodystrophy, sometimes referred to as Berardinelli-Seip syndrome, is an uncommon lipodystrophy variant with significant and sometimes near-total fat loss.

Familial Partial Lipodystrophy

Familial partial lipodystrophy is most often an autosomal dominant condition with fat loss primarily involving the extremities, more commonly lower than upper.

Acquired Generalized Lipodystrophy

Acquired generalized lipodystrophy is an extremely rare condition of widespread subcutaneous fat loss.

Acquired Partial Lipodystrophy

Acquired partial lipodystrophy, or Barraquer-Simons syndrome, is characterized by gradual loss of fat from the upper body and truncal region during childhood. Over the past few decades, however, highly active anti-retroviral therapy induced lipodystrophy has become the most common form of acquired partial lipodystrophy.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Kelly Quinn declares no relevant financial relationships with ineligible companies.

Disclosure: Shaylika Chauhan declares no relevant financial relationships with ineligible companies.

Disclosure: Stephen Purcell declares no relevant financial relationships with ineligible companies.

References

    1. Kushchayeva YS, Kushchayev SV, Startzell M, Cochran E, Auh S, Dai Y, Lightbourne M, Skarulis M, Brown RJ. Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes. J Clin Endocrinol Metab. 2019 Jun 01;104(6):2216-2228. - PMC - PubMed
    1. Gentile S, Strollo F, Guarino G, Diabetologists. Nurses Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest? Diabetes Metab Syndr. 2019 Jan-Feb;13(1):682-686. - PubMed
    1. Elias CP, Antunes DE, Coelho MS, de Lima CL, Rassi N, de Melo APM, Amato AA. Evaluation of the hypothalamic-pituitary-adrenal axis in a case series of familial partial lipodystrophy. Diabetol Metab Syndr. 2019;11:1. - PMC - PubMed
    1. Gentile S, Strollo F, Ceriello A, AMD-OSDI Injection Technique Study Group Lipodystrophy in Insulin-Treated Subjects and Other Injection-Site Skin Reactions: Are We Sure Everything is Clear? Diabetes Ther. 2016 Sep;7(3):401-9. - PMC - PubMed
    1. Blanco M, Hernández MT, Strauss KW, Amaya M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 2013 Oct;39(5):445-53. - PubMed

Publication types

LinkOut - more resources